The CRL3-KEAP1-NRF2 pathway contributions to cancer development are reinforced by the observed deregulation of KEAP1 and the presence of CUL3 mutations that could lead to NRF2 overexpression in many cancers (Chen and Chen, 2016 and references therein). Here, CUL3 is linked to cancer.